BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 16595017)

  • 61. Crystal structure of a wild-type Cre recombinase-loxP synapse reveals a novel spacer conformation suggesting an alternative mechanism for DNA cleavage activation.
    Ennifar E; Meyer JE; Buchholz F; Stewart AF; Suck D
    Nucleic Acids Res; 2003 Sep; 31(18):5449-60. PubMed ID: 12954782
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PepA and ArgR do not regulate Cre recombination at the bacteriophage P1 loxP site.
    MacDonald AI; Lu Y; Kilbride EA; Akopian A; Colloms SD
    Plasmid; 2008 Mar; 59(2):119-26. PubMed ID: 18226834
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alteration of Cre recombinase site specificity by substrate-linked protein evolution.
    Buchholz F; Stewart AF
    Nat Biotechnol; 2001 Nov; 19(11):1047-52. PubMed ID: 11689850
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Expression of cre gene in Escherichia coli and bioassay its expression product].
    Wang LX; Zhang ZQ; Hu XQ; Hu YL; Gao Y; Lin ZP
    Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):497-500. PubMed ID: 12385251
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Construction of engineered murine embryonic stem cells with conditional knockout of FGFR2 depending on Cre-loxP.
    Jianmin W; Ruihua S; Lei C; Liangjun Y; Bo C; Jing S; Yuanbing G; Ling Z; Lin C
    Biocell; 2006 Aug; 30(2):269-78. PubMed ID: 16972551
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Construction of marker-free transplastomic tobacco using the Cre-loxP site-specific recombination system.
    Lutz KA; Svab Z; Maliga P
    Nat Protoc; 2006; 1(2):900-10. PubMed ID: 17406323
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.
    Score PR; Belur LR; Frandsen JL; Geurts JL; Yamaguchi T; Somia NV; Hackett PB; Largaespada DA; McIvor RS
    Mol Ther; 2006 Mar; 13(3):617-24. PubMed ID: 16356773
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A novel binary vector to get marker-free transgenic plant].
    Li X; Weng HB; Han SY; Xi Y; Yong KL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jul; 22(4):550-4. PubMed ID: 16894886
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Highly efficient transgene-independent recombination directed by a maternally derived SOX2CRE transgene.
    Vincent SD; Robertson EJ
    Genesis; 2003 Oct; 37(2):54-6. PubMed ID: 14595840
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conditional expression of anti-apoptotic protein p35 by Cre-mediated DNA recombination in cardiomyocytes from loxP-p35-transgenic mice.
    Araki T; Shibata M; Takano R; Hisahara S; Imamura Si; Fukuuchi Y; Saruta T; Okano H; Miura M
    Cell Death Differ; 2000 May; 7(5):485-92. PubMed ID: 10800082
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Directed evolution of the site specificity of Cre recombinase.
    Santoro SW; Schultz PG
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4185-90. PubMed ID: 11904359
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Minimal cross-recombination between wild-type and loxP511 sites in vivo facilitates truncating both ends of large DNA inserts in pBACe3.6 and related vectors.
    Shakes LA; Garland DM; Srivastava DK; Harewood KR; Chatterjee PK
    Nucleic Acids Res; 2005 Aug; 33(13):e118. PubMed ID: 16061933
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Minimization of the Escherichia coli genome using a Tn5-targeted Cre/loxP excision system.
    Yu BJ; Sung BH; Koob MD; Lee CH; Lee JH; Lee WS; Kim MS; Kim SC
    Nat Biotechnol; 2002 Oct; 20(10):1018-23. PubMed ID: 12244329
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cre recombinase activity is inhibited in vivo but not ex vivo by a mutation in the asymmetric spacer region of the distal loxP site.
    Arguello T; Moraes CT
    Genesis; 2015 Nov; 53(11):695-700. PubMed ID: 26331883
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identifying determinants of recombination specificity: construction and characterization of chimeric bacteriophage integrases.
    Yagil E; Dorgai L; Weisberg RA
    J Mol Biol; 1995 Sep; 252(2):163-77. PubMed ID: 7674299
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cre/loxP-mediated deletion system for large genome rearrangements in Corynebacterium glutamicum.
    Suzuki N; Tsuge Y; Inui M; Yukawa H
    Appl Microbiol Biotechnol; 2005 Apr; 67(2):225-33. PubMed ID: 15834716
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cre-loxP-mediated DNA flip-flop in mammalian cells leading to alternate expression of retrovirally transduced genes.
    Kano M; Igarashi H; Saito I; Masuda M
    Biochem Biophys Res Commun; 1998 Jul; 248(3):806-11. PubMed ID: 9704009
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of deletion mutation on the recombination activity of Cre recombinase.
    Rongrong L; Lixia W; Zhongping L
    Acta Biochim Pol; 2005; 52(2):541-4. PubMed ID: 15912212
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selection-marker-free modification of the murine beta-casein gene using a lox2272 [correction of lox2722] site.
    Kolb AF
    Anal Biochem; 2001 Mar; 290(2):260-71. PubMed ID: 11237328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.